Abstract
IntroductionMitochondrial diseases (MD) are genetically heterogeneous disorders caused by impaired oxidative phosphorylation (OXPHOS). Pathogenic variants in mitochondrial DNA (mtDNA) genes encoding mitochondrial transfer RNAs (mt-tRNAs) represent a significant subgroup, yet many rare variants remain poorly characterized. Cardiac involvement is recognized but may be subclinical and underdetected. This study aimed to characterize and expand the clinical, molecular, and biochemical phenotype of four rare mtDNA variants (m.4300A>G, m.4404T>C, m.7507A>G, and m.608A>G) through detailed phenotyping. In addition, we assessed cardiac involvement with electrocardiography and speckle-tracking echocardiography. MethodsWe conducted a retrospective case series of four pediatric patients at a national mitochondrial expertise center. Clinical, genetic, biochemical, and histological data were collected. Cardiac evaluation included electrocardiography, conventional echocardiography, and two-dimensional speckle-tracking strain imaging. A targeted literature review was performed for all variants. ResultsDisease onset occurred in early childhood, with phenotypes ranging from isolated mitochondrial myopathy to progressive multisystem encephalomyopathy. Cardiac symptoms were absent or mild. Mild ECG abnormalities were consistently present, including QRS fragmentation, repolarization changes, and microvoltages. Conventional echocardiography was normal in all patients. Speckle-tracking echocardiography was abnormal in two patients: one showed mildly reduced global longitudinal strain, whereas another showed regional wall-motion abnormalities despite preserved global strain. The m.4404T>C variant is reported for the first time, and the other variants extend beyond previously described organ-specific presentations. ConclusionRare mtDNA variants affecting mt-tRNA genes show marked phenotypic heterogeneity and may include subclinical cardiac abnormalities despite normal conventional echocardiography. Speckle-tracking echocardiography may add value to longitudinal cardiac phenotyping in pediatric mitochondrial disease.